Immune CD8+ T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 5869-5876

  Khan, Imtiaz A ^a   Green, William R ^a   Kasper, Lloyd H ^a   Green, Kathy A ^a   Schwartzman, Joseph D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HOST RESISTANCE; IMMUNE DEFICIENCY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0032707637     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.5869-5876.1999     Document Type: Article

References (40)

1. + cytolytic T lymphocytes by dendritic cells. Adv. Exp. Med. Biol. 378:375-379.
2. + T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145: 3438-3441.
3. + T cells in murine acquired immunodeficiency syndrome: evidence for an intrinsic defect in the proliferative response to soluble antigen. Eur. J. Immunol. 20:1577-1581.
4. Cingolani, A., A. De Luca, A. Ammassari, R. Murri, A. Linzalone, R. Grillo, and A. Antinori. 1996. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J. Med. Microbiol. 45:472-476.
5. Dannemann, B., J. A. McCutchan, D. Israelski, D. Antoniskis, C. Leport, B. Luft, J. Nussbaum, N. Clumeck, P. Morlat, J. Chiu, et al. 1992. Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann. Intern. Med. 116:33-43.
6. + T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. Res. Immunol. 144:51-57.
7. + T cell memory. Immunol. Rev. 150:23-44.
8. Doherty, T. M., H. C. Morse III, and R. L. Coffman. 1995. Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses. Int. Immunol. 7:131-138.
9. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii J. Immunol. 149:175-180.
10. Gazzinelli, R. T., J. W. Hartley, T. N. Fredrickson, S. K. Chattopadhyay, A. Sher, and H. C. Morse III. 1992. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect. Immun. 60:4394-4401.
11. Grant, I. H., J. W. Gold, M. Rosenblum, D. Niedzwiecki, and D. Armstrong. 1990. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 4:519-521.
12. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:2310-2316.
13. + T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS. Blood 81:2093-2101.
14. Hugin, A. W., A. Cerny, and H. C. Morse III. 1994. Mice with an acquired immunodeficiency (MAIDS) develop a persistent infection after injection with Listeria monocytogenes. Cell. Immunol. 155:245-252.
15. + T cell clone protects against acute Toxoplasma gondii infection in mice. J. Immunol. 152:1855-1860.
16. + T cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147:3501-3506.
17. + T cell-mediated immunity against Toxoplasma gondii infection in mice. J. Immunol. 157: 2103-2108.
18. Khan, I. A., K. A. Smith, and L. H. Kasper. 1990. Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii. J. Clin. Investig. 85:1879-1886.
19. Klinken, S. P., T. N. Fredrickson, J. W. Hartley, R. A. Yetter, and H. C. Morse III. 1988. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J. Immunol. 140: 1123-1131.
20. Lang, W., J. Miklossy, J. P. Deruaz, G. P. Pizzolato, A. Probst, T. Schaffner, E. Gessaga, and P. Kleihues. 1989. Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol. 77:379-390.
21. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222.
22. + T cells in resistance to murine AIDS in A/J mice. J. Immunol. 149:1702-1706.
23. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
24. + T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation. Viral Immunol. 4:177-186.
25. Morse, H., C., III, R. A. Yetter, C. S. Via, R. R. Hardy, A. Cerny, K. Hayakawa, A. W. Hugin, M. W. Miller, K. L. Holmes, and G. M. Shearer. 1989. Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J. Immunol. 143:844-850.
26. Mosier, D. E., R. A. Yetter, and H. C. Morse III. 1985. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:766-784.
27. Neter, J., W. Wasserman, and M. H. Kuter. 1985. Applied linear statistical models, 2nd ed. Irwin, Homewood, Ill.
28. Rosenberg, A. S., T. G. Maniero, and H. C. Morse III. 1991. In vivo immunologie deficits in mice with murine acquired immunodeficiency syndrome and the effect of LP-BM5 infection on rejection of skin from infected mice. Transplant. Proc. 23:167-169.
29. Rowe, W. P., W. E. Pugh, and J. W. Hartley. 1970. Plaque assay techniques for murine leukemia viruses. Virology 42:1136-1139.
30. Shearer, G. M., D. C. Bernstein, K. S. Tung, C. S. Via, R. Redfield, S. Z. Salahuddin, and R. C. Gallo. 1986. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J. Immunol. 137:2514-2521.
31. Sher, A., E. Y. Denkers, and R. T. Gazzinelli. 1995. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. CIBA Found. Symp. 195:95-104.
32. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147:3955-3959.
33. Suzuki, Y., F. K. Conley, and J. S. Remington. 1990. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infect. Immun. 58:3050-3055.
34. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
35. + immune T cells against toxoplasmosis in mice. J. Immunol. 144:1954-1956.
36. Swain, S. L., M. Croft, C. Dubey, L. Haynes, P. Rogers, X. Zhang, and L. M. Bradley. 1996. From naive to memory T cells. Immunol. Rev. 150:143-167.
37. + T cells. Cancer Immunol. Immunother. 46:128-136.
38. + T cells or perform. J. Virol. 71:1808-1813.
39. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
40. + cells used for adoptive immunotherapy of patients infected with human immunodeficiency virus. Blood 81:2085-2092.